Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

India Unhappy about China’s Dominance in Antibiotic APIs

publication date: Jun 5, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
India wants its generic drug industry to be self-sufficient. However, the country remains dependent upon China’s API and drug intermediate companies, especially in the areas of penicillin-type antibiotics. Although India is home to a vibrant group of companies that produce finished generic drugs, these companies source many of their raw materials from China—about two-thirds of the total. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors